index.php
 

Articles • Medscape Medical News Headlines

A phase III trial of enzastaurin for treatment of recurrent glioblastoma was stopped after an interim analysis showed it did not outperform lomustine.
Reuters Health Information ... more
Tags: lomustine, glioblastoma, recurrent, enzastaurin,